Citius Oncology Inc (CTOR)
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
$0.50-8.57%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
QuarterlyIQ Insights · CTOR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | |
|---|---|---|---|---|---|---|
| Operating Expenses & Income | ||||||
| R&D Expenses | 3.4 | 6.4 | 4.9 | 4.2 | — | — |
| Operating Income | (47.3) | (23.5) | — | (0.1) | — | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | 0.2 | — | — | — | — |
| Interest & Investment Income | — | 0.0 | — | — | — | — |
| Other Non-Operating Income / Expenses | — | (0.2) | — | 0.5 | — | — |
| EBT, Incl. Unusual Items | (45.9) | (23.7) | (20.6) | (12.1) | — | — |
| Income Tax Expense | 0.2 | 1.1 | 0.6 | 0.6 | — | — |
| Net Income | ||||||
| Net Income | (46.1) | (24.8) | (21.1) | (12.7) | — | — |
| Per Share | ||||||
| Basic EPS | (0.43) | (0.34) | (0.31) | (0.19) | — | — |
| Diluted EPS | (0.43) | (0.34) | (0.31) | (0.19) | — | — |
| Basic Weighted Avg Shares | 107.9 | 73.3 | 68.1 | 67.5 | — | — |
| Diluted Weighted Avg Shares | 107.9 | 73.3 | 68.1 | 67.5 | — | — |
| Supplemental | ||||||
| EBIT | (47.3) | (23.5) | — | (0.1) | — | — |
| Effective Tax Rate | -0.4% | — | — | -4.8% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.